Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
2,015
Views
11
CrossRef citations to date
0
Altmetric
Back Matter

Pre-treatment tumor neo-antigen responses in draining lymph nodes are infrequent but predict checkpoint blockade therapy outcome

Shaokang Maa National Centre for Asbestos Related Diseases, University of Western Australia, Nedlands, AustraliaView further author information
,
Jonathan Cheea National Centre for Asbestos Related Diseases, University of Western Australia, Nedlands, AustraliaORCID Iconhttps://orcid.org/0000-0002-7986-2708View further author information
ORCID Icon,
Vanessa S. Feara National Centre for Asbestos Related Diseases, University of Western Australia, Nedlands, AustraliaView further author information
,
Catherine A. Forbesa National Centre for Asbestos Related Diseases, University of Western Australia, Nedlands, AustraliaView further author information
,
Louis Boonb Bioceros B.V., Utrecht, NetherlandsORCID Iconhttps://orcid.org/0000-0002-0937-9171View further author information
ORCID Icon,
Ian M. Dicka National Centre for Asbestos Related Diseases, University of Western Australia, Nedlands, AustraliaORCID Iconhttps://orcid.org/0000-0003-1902-9033View further author information
ORCID Icon,
Bruce W. S. Robinsona National Centre for Asbestos Related Diseases, University of Western Australia, Nedlands, Australia;c Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, AustraliaView further author information
&
Jenette Creaneya National Centre for Asbestos Related Diseases, University of Western Australia, Nedlands, Australia;c Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Australia;d Institute of Respiratory Health, University of Western Australia, Nedlands, AustraliaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9391-9395View further author information
ORCID Icon show all
Article: 1684714 | Received 11 Sep 2019, Accepted 22 Oct 2019, Published online: 07 Nov 2019

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Alec J. Redwood, Ian M. Dick, Jenette Creaney & Bruce W. S. Robinson. (2022) What’s next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination. OncoImmunology 11:1.
Read now

Articles from other publishers (10)

Shiya Yao, Huanrong Lan, Yuejun Han, Chunsen Mao, Mengxiang Yang, Xuan Zhang & Ketao Jin. (2023) From organ preservation to selective surgery: How immunotherapy changes colorectal surgery?. Surgery Open Science 15, pages 44-53.
Crossref
Lukasz Kuryk, Giulia Rodella, Monika Staniszewska, Katarzyna Wanda Pancer, Magdalena Wieczorek, Stefano Salmaso, Paolo Caliceti & Mariangela Garofalo. (2022) Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects. Frontiers in Oncology 12.
Crossref
Bruce W.S. Robinson, Alec J. Redwood & Jenette Creaney. (2022) How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New Therapies. Frontiers in Pharmacology 13.
Crossref
Marie Shamseddin, Joanna Obacz, Mathew J Garnett, Robert Campbell Rintoul, Hayley Elizabeth Francies & Stefan John Marciniak. (2021) Use of preclinical models for malignant pleural mesothelioma. Thorax 76:11, pages 1154-1162.
Crossref
Vanessa S. Fear, Catherine A. Forbes, Samuel A. Neeve, Scott A. Fisher, Jonathan Chee, Jason Waithman, Shao Kang Ma, Richard Lake, Anna K. Nowak, Jenette Creaney, Matthew D. Brown, Christobel Saunders & Bruce W. S. Robinson. (2021) Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used. Cancer Immunology, Immunotherapy 70:11, pages 3249-3258.
Crossref
Shamin LiYannick SimoniSummer Zhuang, Austin Gabel, Shaokang MaJonathan Chee, Laura Islas, Anthony Cessna, Jenette Creaney, Robert K. Bradley, Alec Redwood, Bruce W. Robinson & Evan W. Newell. (2021) Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies. Proceedings of the National Academy of Sciences 118:30.
Crossref
Haimei Zhou, Huamei He, Ruijing Liang, Hong Pan, Ze Chen, Guanjun Deng, Shengping Zhang, Yifan Ma, Lanlan Liu & Lintao Cai. (2021) In situ poly I:C released from living cell drug nanocarriers for macrophage-mediated antitumor immunotherapy. Biomaterials 269, pages 120670.
Crossref
Nicola Principe, Joel Kidman, Siting Goh, Caitlin M. Tilsed, Scott A. Fisher, Vanessa S. Fear, Catherine A. Forbes, Rachael M. Zemek, Abha Chopra, Mark Watson, Ian M. Dick, Louis Boon, Robert A. Holt, Richard A. Lake, Anna K. Nowak, Willem Joost Lesterhuis, Alison M. McDonnell & Jonathan Chee. (2020) Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy. Frontiers in Immunology 11.
Crossref
Joel Kidman, Nicola Principe, Mark Watson, Timo Lassmann, Robert A. Holt, Anna K. Nowak, Willem Joost Lesterhuis, Richard A. Lake & Jonathan Chee. (2020) Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses. Frontiers in Immunology 11.
Crossref
Alexander J. Najibi & David J. Mooney. (2020) Cell and tissue engineering in lymph nodes for cancer immunotherapy. Advanced Drug Delivery Reviews 161-162, pages 42-62.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.